Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01755767
Title Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma Who Have Been Treated With One Prior Therapy
Acronym METIV-HCC
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Daiichi Sankyo Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | NZL | NLD | ITA | FRA | ESP | DEU | CHE | CAN | BRA | BEL | AUT | AUS | ARG


No variant requirements are available.